BioTime Reports Third Quarter 2018 Financial Results and Provides Business Update

ALAMEDA, Calif.--(BUSINESS WIRE)--$BTX--BioTime, Inc. (NYSE American:BTX), a clinical-stage biotechnology company focused on degenerative diseases, reported financial and operating results for the third quarter ended September 30, 2018. BioTime management will host a conference call and webcast today at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time to provide a business update. “I am excited to have joined BioTime at a pivotal time in the Company’s development. This past quarter is a great example of

Full Story →